Dermatology Market Research Reports & Industry Analysis
A dermatologist is a doctor, who through several years of post medical school training, specializes in the treatment of skin, hair, and nails. The diagnosis, treatment, and prevention of skin cancers, melanomas, moles, and other skin tumors are some of the most common focuses of a dermatologist. Other conditions commonly treated are acne, rashes (such as psoriasis and lichen planus), impetigo, herpes zoster, syphilis, and fungal diseases (i.e. athletes foot).
In addition to treating pathological skin conditions, dermatologists have become leaders in the field of cosmetic surgery. Some of the procedures frequently performed by cosmetic dermatologists include, but are not limited to; botox injections, collagen treatments, liposuction, laser skin therapies (for hair removal, skin resurfacing, tattoo removal, etc), and varicose vein removal.
Dermatology Industry Research & Market Reports
-
Tinea Pedis (Athlete`s Foot) Treatment
... Billion by 2030, growing at a CAGR of 3.0% over the analysis period 2024-2030. Topical, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$756.3 Million by ... Read More
-
Acne Drugs
... CAGR of 6.9% over the analysis period 2024-2030. Inflammatory, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$9.6 Billion by the end of the analysis period. ... Read More
-
Canine Atopic Dermatitis
... at a CAGR of 8.2% over the analysis period 2024-2030. Glucocorticoids, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$1.0 Billion by the end of the ... Read More
-
Impetigo Drugs
... CAGR of 4.4% over the analysis period 2024-2030. Fusidane Drug, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$883.5 Million by the end of the analysis ... Read More
-
Radiodermatitis
... 4.2% over the analysis period 2024-2030. Topical, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$412.0 Million by the end of the analysis period. Growth in ... Read More
-
Alopecia Drugs
... CAGR of 5.5% over the analysis period 2024-2030. Topical Drugs, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$8.4 Billion by the end of the analysis ... Read More
-
Phototherapy Equipment
... CAGR of 3.5% over the analysis period 2024-2030. LED Phototherapy Equipment, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$238.9 Million by the end of the ... Read More
-
Dermatology Devices
... CAGR of 9.5% over the analysis period 2024-2030. Treatment Devices, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$20.5 Billion by the end of the analysis ... Read More
-
Cosmetic Procedures and Products
... 2030, growing at a CAGR of 6.8% over the analysis period 2024-2030. Facial Injectable, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$22.1 Billion by the ... Read More
-
Botulinum Toxin
... CAGR of 8.8% over the analysis period 2024-2030. Type A, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$11.0 Billion by the end of the analysis ... Read More
-
Rosacea Treatment Market Report by Type (Erythematotelangiectatic Rosacea, Papulopustular Rosacea, Ocular Rosacea, Phymatous Rosacea), Drug Class (Antibiotics, Alpha Agonists, Retinoids, Corticosteroids, Immunosuppressants, Antihypertensive Agents, and Others), Route of Administration (Topical, Oral), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, and Others), End User (Hospitals, Homecare, Specialty Clinics, and Others), and Region 2025-2033
... The rising demand for oral treatments and the expanding pharmaceutical industry are primarily driving the market. Rosacea treatment refers to preventive measures adopted to cure a chronic skin disease that enlarges blood vessels and causes ... Read More
-
Hyaluronic Acid-based Dermal Fillers
... 2030, growing at a CAGR of 7.0% over the analysis period 2024-2030. Single Phase, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$4.6 Billion by the ... Read More
-
Hypertrophic and Keloid Scar Treatment
... Billion by 2030, growing at a CAGR of 9.7% over the analysis period 2024-2030. Topical, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$7.3 Billion by ... Read More
-
Skin Tightening
... CAGR of 6.2% over the analysis period 2024-2030. Radio Frequency Skin Tightening, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$3.3 Billion by the end of ... Read More
-
Dermatology Diagnostic Devices
... at a CAGR of 9.2% over the analysis period 2024-2030. Lasers, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$19.2 Billion by the end of the ... Read More
-
Aesthetic Services
... CAGR of 7.0% over the analysis period 2024-2030. Surgical, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$17.1 Billion by the end of the analysis period. ... Read More
-
Hyperpigmentation Disorders Treatment
... at a CAGR of 5.9% over the analysis period 2024-2030. Topical Drugs, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$3.3 Billion by the end of ... Read More
-
Skin Allergy Therapeutics
... at a CAGR of 5.3% over the analysis period 2024-2030. The U.S. Market is Estimated at US$492.4 Million While China is Forecast to Grow at 8.3% CAGR The Skin Allergy Therapeutics market in the U.S. ... Read More
-
Atopic Dermatitis Drugs
... at a CAGR of 21.1% over the analysis period 2024-2030. Biologics, one of the segments analyzed in the report, is expected to record a 22.7% CAGR and reach US$18.7 Billion by the end of the ... Read More
-
Crow`s Feet Treatment
... at a CAGR of 3.9% over the analysis period 2024-2030. Dermal Fillers, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$450.8 Million by the end of ... Read More
-
Dermatoscopes
... 13.1% over the analysis period 2024-2030. Contact Dermatoscope, one of the segments analyzed in the report, is expected to record a 13.2% CAGR and reach US$2.1 Billion by the end of the analysis period. Growth ... Read More
-
Lifestyle Drugs
... CAGR of 3.1% over the analysis period 2024-2030. Obesity, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$21.4 Billion by the end of the analysis period. ... Read More
-
Dermatology (UK) - Industry Report
... attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Dermatology (UK) report will tell you the companies that have a declining financial ... Read More
-
Clinical Trial Supplies Market by Services (Manufacturing, Sourcing, Packaging, Labelling, Logistics), Phases, Type (Small Molecules, Biologics, Vaccines), Therapeutic Areas (Oncology, Neurology, CVD, Ophthalmology, Dermatology) - Global Forecast to 2030
... the increasing volume and complexity of global clinical trials, the rise of personalized medicine, and stringent regulatory requirements. Decentralized and adaptive trial designs are fueling demand for specialized supply chain solutions, including direct-to-patient logistics and ... Read More
-
Contract Research Organization Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type (Early Phase Development Services, Clinical Research Services, Laboratory Services, and Post-Approval Services), Product Type (Cell and Gene Therapy, Biosimilars, Antibody Drug Conjugates, and Others), Type (In-house and Outsource), Application (Oncology, Neurology, Cardiology, Infectious Diseases, Metabolic Disorder, Nephrology, Respiratory, Dermatology, Ophthalmology, Hematology, and Others), End User (Pharmaceutical and Biotech Companies, Medical Device Companies, Academic and Research Institutes, and Others) and Geography
... driving the market growth include increased outsourcing of R&D and rising demand for clinical trials further are likely to boost the market during the forecast period. However, high competition among CROs among the market deterrents. ... Read More
Research Assistance
